After spinning off from associated company, Shiner Pharm Corp. was funded in 2011 as a consequence of strengthening research development capability and targeting global presence.
Shiner is focusing on developing and commercializing innovative hospital specialty products, and we focus on medicines that make a significant improvement in the health of patients and reduce the burden of disease.
